Concepedia

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial

John G.F. Cleland, John R. Teerlink, Roxy Senior, Evgeny M. Nifontov, John Murray, Chim C. Lang, Vitaly A. Tsyrlin, Barry Greenberg, Jamil Mayet, Dárrel P. Francis,

The Lancet · 2011 · 331 citations · 14 references

DOI

Concepts

References

14

The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure

John G.F. Cleland, Jean‐Claude Daubert, Erland Erdmann et al. · New England Journal of Medicine · 2005 · 6.3K citations · Full text

, , +11

Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events

Arthur J. Moss, William J. Hall, David S. Cannom et al. · New England Journal of Medicine · 2009 · 3.1K citations

, , +10

Short-term Intravenous Milrinone for Acute Exacerbation of Chronic Heart Failure<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Michael S. Cuffe · JAMA · 2002 · 1.2K citations

, , +17

Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure.

Judith K. Gwathmey, L Copelas, Roderick MacKinnon et al. · Circulation Research · 1987 · 924 citations · Full text

, , +17

A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure

Jay N. Cohn, Sidney Goldstein, Barry Greenberg et al. · New England Journal of Medicine · 1998 · 614 citations

, , +9